Delivery Order SPE2DB22D3102-SPE2DB25FL3DW
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $3.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of EUFLEXXA 1% 20 mg/2 ml syringes with a ceiling value of $3,670.26. EUFLEXXA is a hyaluronic acid-based injectable treatment used for knee osteoarthritis pain management. This competitive delivery order, executed under firm fixed pricing, represents a continuation of the federal medical procurement relationship between the prime contractor and the...
- The Defense Logistics Agency awarded a delivery order valued at $5,342.85 to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 ml syringes on September 11, 2025, with completion scheduled for September 12, 2025. EUFLEXXA is a hyaluronic acid-based injectable treatment commonly used for knee osteoarthritis pain management. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $10,745.36 to AmerisourceBergen Drug Corp for the supply of EUFLEXXA 1% 20 mg/2 mL syringes on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. EUFLEXXA is a hyaluronic acid-based injectable product used for osteoarthritis treatment, representing...
- The Defense Logistics Agency awarded a $4,680.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 mg/2 mL syringes (2 mL quantity) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $3,962.99 and an ultimate completion date of September 10, 2025. Euflexxa is a viscosupplement injection used to treat knee osteoarthritis pain. This is a firm fixed price delivery order with no set-aside designation, placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $36,127.60 firm fixed price delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes on August 20, 2025, with completion targeted for August 21, 2025. Euflexxa is a hyaluronic acid-based injectable used for knee osteoarthritis pain management. This non-set-aside contract was competitively awarded and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a...
- The Defense Logistics Agency awarded a $23.6K delivery order to AmerisourceBergen Drug Corp for EUFLEXXA 1% 20 MG/2 ML syringes on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with DLA, leveraging the company's position as a critical distributor of medical products for federal healthcare systems. The award carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Euflexxa 1% 20 mg/2 ml syringes valued at $4,650.21 with a completion date of September 8, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal vendor for military and veteran healthcare systems. The contract represents a...
- The Defense Logistics Agency awarded a $3,153.30 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Euflexxa 1% 20 mg/2 ml syringes. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with a completion date of August 14, 2025, and performance to be executed in Conshohocken, Pennsylvania, where the vendor maintains its corporate office. The product is a hyaluronic acid injection used for osteoarthritis management,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,389.77 firm fixed-price contract is for the supply of EUFLEXXA 20 MG/2 ML SYRINGE 2ML, a medical product used for the treatment of osteoarthritis pain. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2023. This order is part of AmerisourceBergen's...